This article is published in collaboration with Scutify, where you can
find real-time markets and stock commentary from Robert Marcin, Cody Willard and others. Download the
Scutify iOS App, the Scutify Android App
or visit Scutify.com.
Medical cannabis improves daily life for millions of people all over the globe and this multi-billion-dollar opportunity is still in its infancy.
The biotech sector will be one of the greatest beneficiaries of the legal cannabis movement and we expect this market to see incremental growth over the next decade. The cannabis industry is at a turning point and after spending several years researching cannabis and developing products, companies are beginning to realize the fruits of their efforts.
The cannabis-biotech opportunity is comprised of some of the best capitalized and most mature public companies and we have identified three firms for investors to monitor.
- GW Pharmaceuticals (GWPH) is changing the landscape of the